How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

0 Calificaciones
0
Episodio
263 of 286
Duración
31min
Idioma
Inglés
Formato
Categoría
No ficción

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.


Escucha y lee

Descubre un mundo infinito de historias

  • Lee y escucha todo lo que quieras
  • Más de 1 millón de títulos
  • Títulos exclusivos + Storytel Originals
  • Precio regular: CLP 7,990 al mes
  • Cancela cuando quieras
Suscríbete ahora
Copy of Device Banner Block 894x1036 3
Cover for How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

Otros podcasts que te pueden gustar...